metastatic urothelial cancer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

metastatic urothelial cancer
Nov 10, 2024, 04:42 | Insight
SITC Urothelial Cancer CPG rapid update v2.4
Society for Immunotherapy of Cancer shared a post on X: “SITC Urothelial Cancer CPG rapid…
Oct 31, 2024, 15:25 | Insight
Markus Eckstein: A step towards precision oncology for urothelial cancer
Markus Eckstein, Senior Physician/Pathologist and Clinician Scientist at the University Hospital Erlangen, shared a post…
Oct 21, 2024, 16:39 | Blog
Amol Akhade: Sacituzumab govitecan is withdrawn from Metastatic urothelial cancer
Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post…
Apr 30, 2024, 11:17 | Insight
New Paper Alert! Targeting NECTIN4. Predicting Response to Enfortumab Vedotin in Metastatic Urothelial Cancer
Targeting NECTIN4. Predicting Response to Enfortumab Vedotin in Metastatic Urothelial Cancer Authors: Niklas Klümper, MD,…
Apr 27, 2024, 14:44 | Insight
Aruni Ghose: Our review delves into the progress across urological malignancies and discusses future directions in ADC development
Aruni Ghose, Internal Medicine Resident at Barts Health NHS Trust, shared a post on LinkedIn:…
Mar 7, 2024, 17:22 | Insight
Mohammad Jad Moussa: The new EVP 'fissure' challenges the dichotomy of cisplatin/platinum fitness
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared on…
Feb 23, 2024, 11:21 | Insight
Shilpa Gupta: We report for the 1st time the role of tumor fraction in ctDNA in patients with metastatic urothelial cancer in real world
Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, shared on X/Twitter: "We report…
Dec 18, 2023, 03:52 | Drugs
FDA approved enfortumab vedotin-ejfv with pembrolizumab for patients with locally advanced or metastatic urothelial cancer
FDA Oncology shared on X: "On December 15, 2023, the Food and Drug Administration (FDA)…
All: 8 Posts: 1 - 100
Special Coverage